2-(2-hydroxynaphthalen-1-yl)-2-[2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)hydrazinyl]acetonitrile
C17H15N5O2 — CID 135409031
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(2-hydroxynaphthalen-1-yl)-2-[2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)hydrazinyl]acetonitrile
2-(2-hydroxynaphthalen-1-yl)-2-[2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)hydrazinyl]acetonitrile (PubChem CID 135409031) has the molecular formula C17H15N5O2 and a molecular weight of 321.34 g/mol. Its IUPAC name is 2-(2-hydroxynaphthalen-1-yl)-2-[2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)hydrazinyl]acetonitrile.
Molecular Properties
| Compound Name | 2-(2-hydroxynaphthalen-1-yl)-2-[2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)hydrazinyl]acetonitrile |
|---|---|
| PubChem CID | 135409031 |
| Molecular Formula | C17H15N5O2 |
| Molecular Weight | 321.34 g/mol |
| Exact Mass | 321.12 |
| IUPAC Name | 2-(2-hydroxynaphthalen-1-yl)-2-[2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)hydrazinyl]acetonitrile |
| SMILES | Cc1cc(=O)[nH]c(NNC(C#N)c2c(O)ccc3ccccc23)n1 |
| InChI | InChI=1S/C17H15N5O2/c1-10-8-15(24)20-17(19-10)22-21-13(9-18)16-12-5-3-2-4-11(12)6-7-14(16)23/h2-8,13,21,23H,1H3,(H2,19,20,22,24) |
| InChIKey | BITKFFANZCHSPD-UHFFFAOYSA-N |
| XLogP | 2.12 |
| TPSA | 113.83 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 321.34 |
| LogP ≤ 5 | 2.12 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'mannich_A(296)', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135409031 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.